HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingjie Yu Selected Research

Colorectal Neoplasms (Colorectal Cancer)

1/2020Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice.
12/2016Bile acid: a potential inducer of colon cancer stem cells.
9/2016Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells.
11/2014Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.
1/2014Metformin: a potential therapeutic agent for recurrent colon cancer.
4/2013Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.
1/2013Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21.
4/2012EGFR regulation of colon cancer stem-like cells during aging and in response to the colonic carcinogen dimethylhydrazine.
7/2011Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.
2/2011Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingjie Yu Research Topics

Disease

67Neoplasms (Cancer)
05/2024 - 05/2003
24Colonic Neoplasms (Colon Cancer)
08/2020 - 05/2003
14Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 05/2003
8Hyperthermia
05/2024 - 11/2020
7Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 07/2017
6Neoplasm Metastasis (Metastasis)
05/2024 - 06/2010
6Carcinogenesis
08/2020 - 03/2006
5Breast Neoplasms (Breast Cancer)
09/2017 - 08/2003
3Melanoma (Melanoma, Malignant)
05/2024 - 12/2021
3Abdominal Obesity
11/2022 - 11/2019
3Infections
03/2022 - 01/2012
3Inflammation (Inflammations)
01/2022 - 01/2015
3Adenoma (Adenomas)
01/2016 - 02/2011
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 12/2022
2Vitamin D Deficiency
11/2022 - 01/2017
2Hepatocellular Carcinoma (Hepatoma)
06/2022 - 10/2020
2Thrombophilia
05/2022 - 03/2022
2Carcinoma (Carcinomatosis)
12/2020 - 09/2017
1Bites and Stings (Sting)
05/2024
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2024
1Poisoning
02/2024
1Mitochondrial Diseases (Mitochondrial Disease)
01/2024
1Liver Neoplasms (Liver Cancer)
02/2023
1Triple Negative Breast Neoplasms
01/2023
1Myopia
11/2022
1Overweight
11/2022
1Hyperglycemia
04/2022
1Wounds and Injuries (Trauma)
02/2022

Drug/Important Bio-Agent (IBA)

14PlatinumIBA
03/2024 - 01/2017
13Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2023 - 01/2008
12Cisplatin (Platino)FDA LinkGeneric
03/2024 - 01/2017
11ProdrugsIBA
03/2024 - 11/2018
10CurcuminIBA
01/2020 - 01/2008
9DNA (Deoxyribonucleic Acid)IBA
02/2023 - 12/2009
8Fluorouracil (Carac)FDA LinkGeneric
01/2014 - 01/2008
8ErbB Receptors (EGF Receptor)IBA
04/2013 - 05/2003
6PolymersIBA
12/2023 - 11/2020
6Proteins (Proteins, Gene)FDA Link
02/2023 - 05/2003
5MicellesIBA
12/2021 - 01/2017
5MicroRNAs (MicroRNA)IBA
08/2020 - 04/2013
4AntibodiesIBA
03/2024 - 05/2003
4Glutathione (Reduced Glutathione)IBA
05/2021 - 03/2019
3hydroxide ionIBA
02/2024 - 01/2017
3Photosensitizing Agents (Photosensitizers)IBA
06/2023 - 09/2021
3DisulfidesIBA
02/2023 - 08/2020
3A-Form DNA (A-DNA)IBA
01/2023 - 01/2018
3VorinostatFDA Link
04/2022 - 09/2021
31-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2021 - 03/2021
3Biomarkers (Surrogate Marker)IBA
11/2019 - 04/2012
3CateninsIBA
12/2016 - 01/2012
3Dasatinib (BMS 354825)FDA Link
07/2011 - 06/2010
2Cetuximab (Erbitux)FDA Link
03/2024 - 03/2005
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2023 - 02/2010
2LigandsIBA
12/2023 - 05/2003
2Alkylating AgentsIBA
02/2023 - 11/2020
2Vitamin DFDA LinkGeneric
11/2022 - 01/2017
2FibrinIBA
05/2022 - 03/2022
2Triglycerides (Triacylglycerol)IBA
04/2022 - 11/2019
2Small Interfering RNA (siRNA)IBA
12/2021 - 01/2017
2Therapeutic UsesIBA
12/2021 - 12/2020
2DNA AdductsIBA
05/2021 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2021 - 07/2019
2Contrast MediaIBA
09/2017 - 07/2017
2Long Noncoding RNAIBA
01/2017 - 01/2016
2Bile Acids and Salts (Bile Acids)IBA
12/2016 - 01/2015
2CarcinogensIBA
11/2015 - 04/2012
2Alkaline PhosphataseIBA
04/2013 - 08/2011
2matrigelIBA
05/2007 - 03/2006
1AlginatesIBA
05/2024
1HydrogelsIBA
05/2024
1ManganeseIBA
05/2024
1Immunoconjugates (Immunoconjugate)IBA
03/2024
1Vitamin B 6IBA
03/2024
1RhodiumIBA
02/2024
1Dihydrolipoyllysine-Residue Acetyltransferase (Dihydrolipoyl Transacetylase)IBA
01/2024
1CopperIBA
01/2024
1Glucose (Dextrose)FDA LinkGeneric
10/2023
1Oxygen (Dioxygen)IBA
10/2023
1Hydroxyl RadicalIBA
10/2023
1Nanoparticle Drug Delivery SystemIBA
06/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2023
1Adenosine Triphosphatases (ATPase)IBA
05/2023
1Vanadates (Orthovanadate)IBA
05/2023
1Ubiquitin-Specific ProteasesIBA
02/2023
1IR1061IBA
01/2023
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
12/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2022
1HDL CholesterolIBA
04/2022
1Histone Deacetylases (Histone Deacetylase)IBA
04/2022
1AcetylesteraseIBA
04/2022
1Drug CarriersIBA
02/2022

Therapy/Procedure

29Therapeutics
05/2024 - 05/2003
16Drug Therapy (Chemotherapy)
12/2023 - 01/2009
7Immunotherapy
05/2024 - 09/2020
5Photochemotherapy (Photodynamic Therapy)
06/2023 - 03/2021
3Photothermal Therapy
01/2023 - 01/2022
3Lasers (Laser)
12/2022 - 01/2021
2Injections
05/2024 - 05/2003
1Precision Medicine
01/2023
1Phototherapy (Light Therapy)
08/2022